Maternal Mortality Clinical Trial
Official title:
Effectiveness of the Education Program on Increasing the Competency Level of Health Cadres in Indonesia
Ending preventable maternal mortality (EPMM): By 2030, every country should reduce its maternal mortality ratio (MMR) by at least two-thirds from the 2010 baseline. In the era of the SDGs, an acceleration of current progress is required to achieve SGD target 3.1, working towards a vision of ending all preventable maternal mortality. In Central Java, one of the most effective efforts to reduce maternal mortality is increasing the number of human resources, who can assist pregnant mothers and supervise their period of pregnancy. The maternal mortality rate (MMR) in Banjarnegara Regency in 2021 is 287.05 per 100,000 live births, this indicates the top 10 in Central Java Province over the past 5 years. Health cadres, who are non-professional volunteer health supporters for pregnant women appointed by regional public health centers (PHCs), are expected to be the key human resources who contribute to reducing MMR in Indonesia and Banjarnegara Regency as well. However, based on an initial study by researchers conducting qualitative research with focus group discussions (FGDs) and in-depth interviews in April-July 2023, researchers found that health cadres had incorrect and unscientific knowledge. Therefore, improving the knowledge and skills of the health cadres through education programs could be expected to further improve the health outcomes of pregnant women, consequently contributing to reducing the MMR. The purpose of this study is to improve health cadres' competency level in monitoring the risks of pregnant women. This monitoring activities for pregnant women by cadres is an effort to prevent maternal mortality, because if there are complications they can be treated as early as possible.
1. Prior to the commencement of the study, the PI will visit the selected PHCs as the intervention group and control group, and then explain an overview of this study. The PI obtained the agreement to participate in this study from the head of the PHC. 2. The PI will ask the coordinator midwife at each PHC to introduce the names and phone numbers of the health cadres who will be potential participants. The PI and the researchers will contact each potential participant one by one to explain the procedure of this study and then obtain their consent to become a participant in this study. Cadres who belong to PHCs will receive the competency-based education program, and those who belong to PHCs allocated to the control group will follow the initial orientation provided by the PHC. 3. The PI and assistant (research team) will create a WhatsApp group for the intervention group and control group, and then distribute the questionnaires at an initial stage. All data will be collected at each PHC where the study will be conducted. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01945931 -
Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia
|
N/A | |
Completed |
NCT01389219 -
Post Partum Maternal and Neonatal Intervention Package
|
N/A | |
Completed |
NCT03299491 -
An Implementation Study of Interventions to Promote Safe Motherhood in Jimma Zone Ethiopia
|
N/A | |
Not yet recruiting |
NCT04904380 -
Impact of New Tools of Simulation-enhanced Peer Learning on Neonatal and Maternal Mortality
|
N/A | |
Enrolling by invitation |
NCT04029207 -
The ASOS-2 Trial Maternal Mortality Sub-study
|
||
Recruiting |
NCT05484804 -
Accountability for Care Through Undoing Racism & Equity for Moms
|
N/A | |
Completed |
NCT03024905 -
Project to Use Community Health Workers to Reduce Maternal Deaths
|
N/A | |
Completed |
NCT01487707 -
Community Based Strategies to Reduce Maternal Mortality in Northern Nigeria
|
N/A | |
Completed |
NCT00211341 -
Trial of the Impact of Vitamin A on Maternal Mortality
|
Phase 3 | |
Completed |
NCT02878226 -
Outcomes of Uterine Rupture
|
||
Completed |
NCT00198822 -
Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
|
Phase 3 |